American tegumentary leishmaniasis

Drug Resistance in Leishmania Parasites: Consequences, Molecular Mechanisms and Possible Treatments

Volumn , Issue , 2013, Pages 199-212

  Zerpa, Olga ^a   Ponte Sucre, Alicia ^b  

^a INSTITUTO DE BIOMEDICINA   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903953042     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-1125-3_10     Document Type: Chapter

References (52)

1. Akilov OE, Khachemoune A, Hasan T (2007) Clinical manifestations and classification of Old World cutaneous leishmaniasis. Int J Dermatol 46:132-142
2. Barral A et al (1995) Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects. Int J Dermatol 34:474-479
3. Bittencourt AL et al (1993) Leishmaniasis recidiva cutis in American cutaneous leishmaniasis. Int J Dermatol 32:802-805
4. Bray RS, Lainson R (1965) The immunology and serology of leishmaniasis the fluorescent antibody staining technique. Trans Roy Soc Trop Med Hyg 59:535-544
5. Calvopina M et al (2006) Leishmaniasis recidiva cutis due to Leishmania (Viannia) panamensis in subtropical Ecuador: isoenzymatic characterization. Int J Dermatol 45:116-120
6. Castes M, Tapia FJ (1998) Inmunopatologia de la leishmaniasis tegumentaria americana. Acta Cient Venezolana 49:42-56
7. Convit J (1996) Leishmaniasis immunological and clinical aspects and vaccines in Venezuela. Clin Dermatol 14:479-487
8. Convit J et al (1989) Inmunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis. J Infect Dis 160:104-115
9. Convit J et al (1993) The clinical and inmunological spectrum of American cutaneous leishmaniasis. Trans Roy Soc Trop Med Hyg 87:444-448
10. Cuba CA et al (2000) DiagniSstico parasitologico e inmunoliSgico de leishmaniasis tegumentaria Americana. Rev Med Exper 17:1-4
11. Davies CR et al (2000) The epidemiology and control of leishmaniasis in Andean countries. Cader Saude Publ 16:925-950
12. de Castro EA et al (2005) Eco-epidemiological survey of Leishmania (Viannia) braziliensis American cutaneous and mucocutaneous leishmaniasis in Ribeira Valley River, Parana State, Brazil. Acta Trop 93:141-149
13. De Lima H et al (2002) Cotton rats and black rats as possible reservoirs of cutaneous leishmaniasis in an endemic area in Lara State, Venezuela. Memior Instit Oswaldo Cruz 97:169-174
14. El-Hassan AM et al (1995) Sudanese mucocutaneous leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment. Trans Roy Soc Trop Med Hyg 89:647-652
15. Feliciangeli MD (1991) Vectors of leishmaniasis in Venezuela. Parassitologia 33:229-236
16. Feliciangeli MD, Rabinovich J (1998) Abundance of Lutzomyia ovallensi but not Lu. Gomezi (Diptera:Psychodidae) correlated with cutaneous leishmaniasis incidence in north-central Venezuela. Med Vet Entomol 12:121-131
17. Feliciangeli MD et al (1994) Vectors of cutaneous leishmaniasis in north-central Venezuela.Med Vet Entomol 8:317-324
18. Garcia AL et al (2009) Leishmaniases in Bolivia: comprehensive review and current status.Am J Trop Med Hyg 80:704-711
19. Gautret P et al (2009) Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe and for the GeoSentinel Surveillance Network. Emerg Infect Dis 15:1783-1790
20. Goto H, Lindoso JA (2010) Current diagnosis and treatment of cutaneous and mucocutaneous Leishmaniasis. Exp Rev Anti-infect Ther 8:419-433
21. Gramiccia M, Gradoni L (2005) The current status of zoonotic leishmaniases and approaches to disease control. Int J Parasitol 35(11-12):1169-1180
22. Grimaldi G Jr, Tesh RB, Mc Mahon-Pratt D (1989) A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am J Trop Med Hyg 41:687-725
23. Jones TC et al (1987) Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis. J Infect Dis 156:73-83
24. Lopez M et al (1993) Diagnosis of Leishmanina using the polymerase chain reaction: a simplified procedure for field work. Am J Trop Med Hyg 49:34-42
25. Machado P et al (2002) Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer. Clin Infect Dis 34:E69-E73
26. Marsden PD (1986) Mucocutaneous leishmaniasis (“Espundia” Escomel, 1911). Trans Roy Soc Trop Med Hyg 80:859-876
27. Moll H (1997) The role of chemokines and accessory cells in the immunoregulation of cutaneous leishmaniasis. Behring Inst Mitt 99:73-78
28. Moll H (2000) The role of dendritic cells at the early stages of Leishmania infection. Adv Exp Med Biol 479:163-173
29. Natera S et al (2007) Leishmania s.p.: proficiency of drug resistant parasites. Int J Antimicrob Agents 29:637-642
30. Oliveira-Neto MP et al (1998) Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis. Int J Dermatol 37:846-849
31. Padron Nieves M et al (2008) Valor proniSstico de los cambios fisiol 5gicos asociados a la quimio-resistencia en Leishmania. Vitae 33: http://vitae.ucv.ve/
32. Ponte-Sucre A (2003) Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy. Kinetoplastid Biol Dis 2:14 http://www.kinetoplastids.com/home/
33. Puig L, Pradinaud R (2003) Leishmania and HIV co-infection: dermatological manifestations.Ann Trop Med Parasitol 97:107-114
34. Reed SG (1996) Diagnosis of leishmaniasis. Clin Dermatol 14:471-478
35. Reithinger R et al (2007) Cutaneous leishmaniasis. Lancet Infect Dis 7:581-596
36. Restrepo IM (1980) La reaccicin de Montenegro en la epidemiologia de la leishmaniasis sudamericana. Bol Oficina Sanit Panam 89:130
37. Ridley DS et al (1980) A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation. Trans Roy Soc Trop Med Hyg 74:508
38. Rodriguez N et al (1994) Diagnosis of cutaneous leishmaniasis and species discrimination of parasites by PCR and hybridization. J Clin Microbiol 32:2246-2252
39. Rondon A (1993) Leishmaniasis tegumentaria americana. Clin Dermatol Venezolana 31:12-17
40. Sanchez MA et al (1993) Epidermal Langerhans cells and dendritic epidermal T cells in murine cutaneos leishmaniasis. Immunocytochemical Study. Acta Microscop 2:180-187
41. Sassi A et al (1999) Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clin Exp Immunol 116:127-132
42. Scarisbrick JJ et al (2006) Clinical features and diagnosis of 42 travellers with cutaneous leishmaniasis. Trav Med Infect Dis 4:14-21
43. Shaw JJ, Lainson R (1975) Leishmaniasis in Brazil: X. Some observations of intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis. Trans Roy Soc Trop Med Hyg 69:323-335
44. Souza AS et al (2010) Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMc Infect Dis 10:209 http://www.biomedcentral.com/1471-2334/10/209
45. Stuart K et al (2008) Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest 118:1301-1310
46. Tapia FJ et al (1994) Adhesion molecules in lesions of American cutaneous leishmaniasis. Exp Dermatol 3:17-22
47. Turetz ML et al (2002) Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 186:1829-1834
48. Ulrich M et al (1995) Differing antibody IgG isotypes in the polar forms of leprosy and cutaneous leishmaniasis characterized by antigen specific T cell anergy. Clin Exp Immunol 100:54-58
49. Weigle KA et al (1987) Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 36:489-496
50. World Health Organization (2010) Control of the leishmaniasis. Technical report series, vol 949, Geneva, 2010
51. Yardley V et al (2006) American tegumentary leishmaniasis: is antimonial treatment outcome related to parasite drug susceptibility? J Infect Dis 194:1168-1175
52. Zijlstra EE et al (2003) Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 3:87-98